BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33038052)

  • 1. CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression.
    Yanai Y; Kosaka T; Nakamura K; Aimono E; Matsumoto K; Morita S; Mikami S; Nishihara H; Oya M
    Cancer Sci; 2020 Dec; 111(12):4652-4655. PubMed ID: 33038052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERBB2-amplified lobular breast carcinoma exhibits concomitant CDK12 co-amplification associated with poor prognostic features.
    Forster-Sack M; Zoche M; Pestalozzi B; Witzel I; Schwarz EI; Herzig JJ; Fansa H; Tausch C; Ross J; Moch H; Varga Z
    J Pathol Clin Res; 2024 Mar; 10(2):e12362. PubMed ID: 38335502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization.
    Ching CB; Amin MB; Tubbs RR; Elson P; Platt E; Dreicer R; Fergany A; Hansel DE
    Mod Pathol; 2011 Aug; 24(8):1111-9. PubMed ID: 21516078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer.
    Reimers MA; Yip SM; Zhang L; Cieslik M; Dhawan M; Montgomery B; Wyatt AW; Chi KN; Small EJ; Chinnaiyan AM; Alva AS; Feng FY; Chou J
    Eur Urol; 2020 Mar; 77(3):333-341. PubMed ID: 31640893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases.
    Hansel DE; Swain E; Dreicer R; Tubbs RR
    Am J Clin Pathol; 2008 Aug; 130(2):274-81. PubMed ID: 18628098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of amplification of c-erb-B2 in bladder carcinoma.
    Lönn U; Lönn S; Friberg S; Nilsson B; Silfverswärd C; Stenkvist B
    Clin Cancer Res; 1995 Oct; 1(10):1189-94. PubMed ID: 9815911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.
    Ross JS; Wang K; Khaira D; Ali SM; Fisher HA; Mian B; Nazeer T; Elvin JA; Palma N; Yelensky R; Lipson D; Miller VA; Stephens PJ; Subbiah V; Pal SK
    Cancer; 2016 Mar; 122(5):702-11. PubMed ID: 26651075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder.
    Lunec J; Challen C; Wright C; Mellon K; Neal DE
    Lancet; 1992 Feb; 339(8790):439-40. PubMed ID: 1346710
    [No Abstract]   [Full Text] [Related]  

  • 11. C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.
    Leonardo C; Merola R; Orlandi G; Leonardo F; Rondoni M; De Nunzio C
    J Exp Clin Cancer Res; 2005 Dec; 24(4):633-8. PubMed ID: 16471327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.
    Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M
    Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Her-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
    Montie JE
    J Urol; 2005 Jun; 173(6):1921-2. PubMed ID: 15879779
    [No Abstract]   [Full Text] [Related]  

  • 14. HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.
    Kim B; Kim G; Song B; Lee C; Park JH; Moon KC
    Dis Markers; 2016; 2016():8463731. PubMed ID: 27034533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-erb-B2 gene in bladder cancer of Egyptian patients and its correlation with p53 and bcl-2.
    Sakr SA; Mahran HA; Fahmy AM; El-Kholy MA; Meawad M
    Biomed Pharmacother; 2015 Dec; 76():73-81. PubMed ID: 26653553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients.
    Gorgoulis VG; Barbatis C; Poulias I; Karameris AM
    Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics.
    Nguyen B; Mota JM; Nandakumar S; Stopsack KH; Weg E; Rathkopf D; Morris MJ; Scher HI; Kantoff PW; Gopalan A; Zamarin D; Solit DB; Schultz N; Abida W
    Eur Urol; 2020 Nov; 78(5):671-679. PubMed ID: 32317181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?
    Latif Z; Watters AD; Dunn I; Grigor K; Underwood MA; Bartlett JM
    Eur J Cancer; 2004 Jan; 40(1):56-63. PubMed ID: 14687790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.
    Isharwal S; Huang H; Nanjangud G; Audenet F; Chen YB; Gopalan A; Fine SW; Tickoo SK; Lee BH; Iyer G; Chadalavada K; Rosenberg JE; Bajorin DF; Herr HW; Donat SM; Dalbagni G; Bochner BH; Solit DB; Reuter VE; Al-Ahmadie HA
    Hum Pathol; 2018 Jul; 77():63-69. PubMed ID: 29601842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of C-erb B2 gene amplification in bilharzial associated bladder cancer using fluorescence in situ hybridization.
    Aly MS; Khaled HM
    Urol Oncol; 2004; 22(6):448-52. PubMed ID: 15610859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.